Wojewódzki Szpital Specjalistyczny W Legnicy
Legnica, Poland
Treatment & access
- Treatments offeredesketamine (Spravato)
- Access routepublic_reimbursed
- Price informationCovered by NFZ (drug programme B.147)
- ReimbursementNFZ drug programme B.147 - leczenie chorych na depresję lekooporną How reimbursement works in Europe →
- Phone+48 76 721 14 22
- Websitehttps://szpital.legnica.pl/
About this provider
Wojewódzki Szpital Specjalistyczny w Legnicy is a regional multi-specialty hospital in Lower Silesia. Per NFZ data it runs program B.147 — fully funded esketamine (Spravato) for treatment-resistant depression — with no queue reported as of June 2026; program contact points are its General Psychiatric Ward, Mental Health Clinic and Day Psychiatric Ward. Its own site describes a General Psychiatric Ward with observation and open sections offering pharmacotherapy, electroconvulsive therapy, psychotherapy and occupational therapy, and a Mental Health Clinic that requires no referral, with a psychologist available daily.
Services & programs
- General Psychiatric Ward (observation section and open section)
- Day Psychiatric Rehabilitation Ward and Day Psychiatric Ward (general)
- Mental Health Clinic (PZP) — no referral required, psychologist available daily
- Pharmacotherapy, electroconvulsive therapy, individual and group psychotherapy, psychoeducation, occupational therapy
Common questions
How do I access the esketamine program in Legnica?
Contact the hospital's psychiatric service — ward secretariat +48 76 721 14 22 or Mental Health Clinic registration +48 76 721 17 03. Program qualification requires being 18-75 with moderate-to-severe depression unresponsive to at least two antidepressants; bring your medical records and a referral.
Do I need a referral to be seen?
The hospital's Mental Health Clinic accepts patients without a referral, so a psychiatrist there can assess you; enrollment in program B.147 itself is decided by the center's physicians against the NFZ criteria.
What is covered by the program?
The full course — esketamine nasal spray administered under supervision at the center, alongside a prescribed oral antidepressant, for up to 34 weeks — is funded by the NFZ at no cost to insured patients.
Verification
- License / registryNFZ B.147
- Sourcehttps://api.nfz.gov.pl/app-itl-api/queues?case=1&benefit=LECZENIE%20CHORYCH%20NA%20DEPRESJ%C4%98%20LEKOOPORN%C4%84
- Last verified